Eurovacc Foundation

Start Date End Date Funded Value Relevance

CSV

25 50 100

£126,495

Mar 21 - Mar 21

A combination efficacy study in Africa of two DNA-MVA- or DNA- Env protein HIV-1 vaccine regimens with pre-exposure prophylaxis (PrEP) – supplementary funding for MPLA-Liposomes

MRC award to Imperial College London and Jonathan Weber

£4,999,000

Apr 21 - Mar 26

Blood borne viruses

MRC award to University College London and Sarah Pett

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}